Framingham, MA · Founded 2013 · Privately Held (backing)
Developer of a small molecule-based drug discovery platform designed to treat Alzheimer's disease and other neurodegenerative disorders. Alzheon is based in Framingham, MA and was founded in 2013. Its last reported valuation was $550 million in Apr 2022. It has raised $212 million across 9 recorded rounds; the latest was a $126 million later-stage round in Feb 2024.
Last reported valuation
$550.0M
Oct 2026
Priced at
—
Total raised
$212.2M
Last round
Later Stage VC
Feb 2024
Team — not yet on record
No current team members for Alzheon are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alzheon with a free account
·Watch Alzheon: the Monday email on marks, rounds and moves
